By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


Company News
Actinium (ATNM.OB) To Present At BIO CEO & Investor Conference 2/9/2017 10:06:37 AM
Actinium (ATNM.OB) Announces Pipeline Expansion With Initiation Of Clinical Trial Of Actimab-M In Multiple Myeloma 2/7/2017 10:42:09 AM
Actinium (ATNM.OB) Release: Pharma Announces Participation In Three Upcoming Hematology Events 1/20/2017 10:56:28 AM
Actinium (ATNM.OB) Release: Pharma Strengthens Executive Team And Enhances Clinical Development Capabilities With The Appointment Of Dr. Mark Berger As Chief Medical Officer 1/18/2017 7:07:09 AM
Actinium (ATNM.OB) To Present At 9th Annual Biotech Showcase 2017 Conference 1/4/2017 10:18:43 AM
Actinium (ATNM.OB) Appoints Jeannine Larrieux, Ph.D. As Director Of Analytical Development To Support BLA And IND Enabling Analytical Studies For Current And Future Clinical Programs 12/19/2016 1:20:54 PM
Actinium (ATNM.OB) Announces Submission Of EU Orphan Designation Application For Actimab-A 12/13/2016 8:01:23 AM
Actinium (ATNM.OB) To Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML 12/12/2016 1:14:15 PM
Actinium (ATNM.OB) Highlights Results From Phase I Clinical Trial Of Actimab-A At 58th American Society of Hematology Annual Meeting 12/6/2016 7:55:43 AM
Actinium (ATNM.OB) Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials 11/29/2016 8:14:01 AM